Upstream Bio Inc (UPB)

$11.00 +0.12 (1.10%)
Market Cap 583.14M
Revenue (ttm) 2.38M
Net Income (ttm) -20.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,607.35%
Debt to Equity Ratio 0.00
Volume 158,600
Avg Vol 332,602
Day's Range N/A - N/A
Shares Out 53.60M
Stochastic %K 1%
Beta N/A
Analysts Strong Sell
Price Target $56.50

Latest News on UPB

Upstream Bio: Treating Respiratory Disorders With TSLP Targeting Differentiation

Dec 16, 2024, 1:03 PM EST - 4 weeks ago

Upstream Bio: Treating Respiratory Disorders With TSLP Targeting Differentiation

Upstream Bio Announces Addition to Russell 2000® Index

Dec 16, 2024, 8:00 AM EST - 4 weeks ago

Upstream Bio Announces Addition to Russell 2000® Index

Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say

Nov 5, 2024, 3:09 PM EST - 2 months ago

Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Oct 15, 2024, 4:15 PM EDT - 3 months ago

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Upstream Bio valued at $1.1 bln as shares jump in Nasdaq debut

Oct 11, 2024, 12:49 PM EDT - 3 months ago

Upstream Bio valued at $1.1 bln as shares jump in Nasdaq debut

Upstream Bio raises $255 mln in US IPO

Oct 10, 2024, 7:42 PM EDT - 3 months ago

Upstream Bio raises $255 mln in US IPO

Upstream Bio Announces Pricing of Upsized Initial Public Offering

Oct 10, 2024, 7:35 PM EDT - 3 months ago

Upstream Bio Announces Pricing of Upsized Initial Public Offering

Respiratory disorder biotech Upstream Bio files for a $100 million IPO

Sep 18, 2024, 5:05 PM EDT - 4 months ago

Respiratory disorder biotech Upstream Bio files for a $100 million IPO

Upstream Bio IPO Registration Document (S-1)

Sep 18, 2024, 4:06 PM EDT - 4 months ago

Upstream Bio IPO Registration Document (S-1)